← Leaderboards
Kelan G Tantisira
University Of California, San Diego
$14,938,349
Attributed
$19,949,985
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,642,709 · 9
By mechanism
R01$18,974,235 · 6
U01$9,692,724 · 1
R21$490,500 · 1
K23$485,250 · 1
Top collaborators
- Scott T Weiss8 shared
- Eugene R Bleecker3 shared
- Geoffrey L Chupp3 shared
- Dawn L Demeo2 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Scott T Weiss$73,772,324
- Eugene R Bleecker$21,321,746
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectAsthmaUnited StatesResponseGenomicsGenesMorbidity - Disease RateCohortGeneticResourcesTreatment ResponseBaseProgramsHealth Care CostsPharmaceutical PreparationsCellsClinical TrialsChildhood AsthmaPharmacogenomicsPlayGene ExpressionPrognosticInvestigationMolecular
Grant awards (32)
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping$2,137,425
R01 · FY2025 · HL · contact PI
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping$2,102,471
R01 · FY2024 · HL · contact PI
Genomics and Pharmacogenomics of Symptoms in Asthma$680,342
R01 · FY2024 · HL · contact PI
Genomics and Pharmacogenomics of Symptoms in Asthma$708,364
R01 · FY2023 · HL · contact PI
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping$2,115,286
R01 · FY2022 · HL · contact PI
Genomics and Pharmacogenomics of Symptoms in Asthma$717,458
R01 · FY2022 · HL · contact PI
Genomics and Pharmacogenomics of Symptoms in Asthma$774,627
R01 · FY2021 · HL · contact PI
MICRORNAS IN CIRCULATION: ONTOLOGIES OF ASTHMA SEVERITY AND TREATMENT (MICROCOAST)$835,212
R01 · FY2018 · HL · contact PI
MICRORNAS IN CIRCULATION: ONTOLOGIES OF ASTHMA SEVERITY AND TREATMENT (MICROCOAST)$841,049
R01 · FY2017 · HL · contact PI
DISEASE AND HEALTH: ASTHMA RESILIENCE THROUGH MICRORNA ATTRIBUTES (DHARMA)$436,400
R01 · FY2017 · HL · contact PI
MICRORNAS IN CIRCULATION: ONTOLOGIES OF ASTHMA SEVERITY AND TREATMENT (MICROCOAST)$848,042
R01 · FY2016 · HL · contact PI
DISEASE AND HEALTH: ASTHMA RESILIENCE THROUGH MICRORNA ATTRIBUTES (DHARMA)$455,832
R01 · FY2016 · HL · contact PI
MICRORNAS IN CIRCULATION: ONTOLOGIES OF ASTHMA SEVERITY AND TREATMENT (MICROCOAST)$910,738
R01 · FY2015 · HL · contact PI
DISEASE AND HEALTH: ASTHMA RESILIENCE THROUGH MICRORNA ATTRIBUTES (DHARMA)$480,221
R01 · FY2015 · HL · contact PI
Pharmacogenetics of Asthma Treatment$1,919,404
U01 · FY2014 · HL
Pharmacogenetics of Asthma Treatment$1,864,564
U01 · FY2013 · HL
INTEGRATIVE PHARMACOGENOMICS OF LEUKOTRIENE INHIBITION IN ASTHMA$681,741
R01 · FY2013 · HL · contact PI
GENOMICS AND PHARMACOGENOMICS OF SYMPTOMS IN ASTHMA$423,045
R01 · FY2013 · NR · contact PI
Pharmacogenetics of Asthma Treatment$1,958,575
U01 · FY2012 · HL
INTEGRATIVE PHARMACOGENOMICS OF LEUKOTRIENE INHIBITION IN ASTHMA$725,119
R01 · FY2012 · HL · contact PI
GENOMICS AND PHARMACOGENOMICS OF SYMPTOMS IN ASTHMA$446,250
R01 · FY2012 · NR · contact PI
CIGARETTE SMOKE IMPACTS FETAL LUNG DNA METHYLATION AND GENE EXPRESSION$223,125
R21 · FY2012 · HL
Pharmacogenetics of Asthma Treatment$1,957,381
U01 · FY2011 · HL
INTEGRATIVE PHARMACOGENOMICS OF LEUKOTRIENE INHIBITION IN ASTHMA$730,852
R01 · FY2011 · HL · contact PI
GENOMICS AND PHARMACOGENOMICS OF SYMPTOMS IN ASTHMA$446,146
R01 · FY2011 · NR · contact PI
CIGARETTE SMOKE IMPACTS FETAL LUNG DNA METHYLATION AND GENE EXPRESSION$267,375
R21 · FY2011 · HL
Pharmacogenetics of Asthma Treatment$1,992,800
U01 · FY2010 · HL
INTEGRATIVE PHARMACOGENOMICS OF LEUKOTRIENE INHIBITION IN ASTHMA$737,027
R01 · FY2010 · HL · contact PI
INTEGRATIVE PHARMACOGENOMICS OF LEUKOTRIENE INHIBITION IN ASTHMA$740,588
R01 · FY2009 · HL · contact PI
Pharmacogenetic Linkage of Corticosteroid Response: Asthma Therapy Implications$161,750
K23 · FY2008 · HG · contact PI
Pharmacogenetic Linkage of Corticosteroid Response: Asthma Therapy Implications$161,750
K23 · FY2007 · HG · contact PI
Pharmacogenetic Linkage of Corticosteroid Response: Asthma Therapy Implications$161,750
K23 · FY2006 · HG · contact PI